Actively Recruiting
Study Compare Adjuvant Chemotherapy, Chemoradiotherapy and Surgery Alone for pN1-2(pT1b-3N1-2M0) Esophageal Carcinoma
Led by Fujian Medical University Union Hospital · Updated on 2021-11-12
819
Participants Needed
1
Research Sites
409 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
A multi-center prospective randomized controlled study was conducted to compare the effects of adjuvant chemotherapy, chemoradiotherapy and surgery alone for the patients with esophageal cancer.
CONDITIONS
Official Title
Study Compare Adjuvant Chemotherapy, Chemoradiotherapy and Surgery Alone for pN1-2(pT1b-3N1-2M0) Esophageal Carcinoma
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Participants volunteer and have signed informed consent
- Underwent radical tumor resection (R0) with confirmed thoracic esophageal squamous cell carcinoma
- No cancer treatment before surgery
- Diagnosed with pN1-2 (pT1b-3N1-2M0) esophageal cancer per 8th AJCC staging
- WHO performance status score of 0-1
- Age between 18 and 75 years, any gender
- Cardiac, liver, and kidney functions meet requirements within one week before adjuvant treatment
You will not qualify if you...
- Surgical approach was left thoracic
- Severe postoperative complications preventing adjuvant therapy
- Received other anti-tumor treatments before enrollment
- Presence of other malignant tumors except non-melanoma skin cancer, in-situ cervical cancer, or cured early prostate cancer
- Abnormal blood clotting or bleeding tendencies or receiving blood-thinning treatments
- Severe heart disease including congestive heart failure, uncontrolled arrhythmia, unstable angina, recent myocardial infarction, severe valve disease, or uncontrolled hypertension
- Severe liver or kidney failure
- Uncontrolled neurological or mental illness, poor compliance, or inability to describe treatment response
- Known or suspected allergy to chemotherapy drugs
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Fujian Medical University Union Hospital
Fuzhou, Fujian, China, 350001
Actively Recruiting
Research Team
B
Bin Zheng, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here